RPS2P16

Across TCGA pan-cancer cohorts, RPS2P16 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated RPS2P16 data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher RPS2P16 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPS2P16 expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCS show a favorable association.

COAD, ACC, and OV are the cancer types where RPS2P16 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	All	0.739	0.860	.001	75	view →
ACC	DFS	Tertile	III,IV	0.075	0.525	.001	50	view →
OV	OS	Median	III,IV	0.627	0.733	.002	48	view →
HNSC	DFS	Tertile	II,III,IV	0.416	0.274	.009	39	view →
UCS	DFS	Median	IV	0.952	0.367	.001	36	view →
MESO	DFS	Tertile	All	0.282	0.517	.004	32	view →
LAML	DFS	Tertile	All	0.678	0.412	.002	30	view →
UVM	DFS	Tertile	III,IV	0.185	1.000	.007	20	view →
THCA	OS	Median	II,III,IV	0.634	1.000	.007	18	view →
KIRC	DFS	Tertile	All	0.556	0.724	.012	13	view →
LIHC	DFS	Quartile	All	0.434	0.600	.022	11	view →
TGCT	DFS	Median	All	0.885	0.711	.006	8	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

RPS2P16–COAD (OS)

Open the COAD breakdown →